Tuesday, January 18, 2011 11:12:35 AM
What: Santarus Analyst Day and Investor Briefing
When: Wednesday, January 19, 2011 at 4:15 p.m. Eastern time
Where: www.santarus.com (under the Investor Relations link)
AGENDA
* Strategic Overview and 2011 Financial Outlook
* CYCLOSET® - Clinical/Medical Background
* ULTESA™ (Budesonide MMX®) – Overview and Top-line Phase III Clinical Study Results
* Ulcerative Colitis – Treatment Perspective
* RHUCIN® and Hereditary Angioedema (HAE)
* SAN-300 (anti-VLA-1 antibody)
* Wrap-up/Question & Answer Session
How: Live over the Internet – Simply log on to the Investor Relations section of the company's website at www.santarus.com
Contact:
Lippert/Heilshorn & Associates
Narine Darbinyan
310-691-7100
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM